Safety and Performance of a New 1-piece Ostomy Product Compared to Standard Care Ostomy Products in Subjects Ileostomy

February 6, 2012 updated by: Coloplast A/S

An Open-labelled, Randomised, Controlled, Comparative, Explorative, Cross-over Study Investigating Safety and Performance of a New 1-piece Ostomy Product Compared Standard Care Ostomy Products in Subjects With Ileostomy

Introduction:

It is not an illness to have an ostomy, even though it is an indication of previous serious illness, such as cancer, which is the reason for approximately 80% of all ostomy operations. Ostomies can be divided into three categories: colostomy (large intestine), ileostomy (small intestine) and urostomy (urinary tract). All require surgical redirection of the intestine or urinary tract, allowing for elimination of urine and faeces by means of an opening in the abdominal wall. For the population included in this study, subject with an ileostomy, colitis ulcerosa is the main cause for an ileostomy where a surgical removal of the colon and rectum resulting in an ileostomy in theory cures the disease.

It can be very challenging to live with an ostomy and modern ostomy products should make life as easy as possible for people with ostomies.

Leakage and peristomal skin problems have been found to have a negative effect on the quality of life for people with ostomies. The skin problems are the reason for one out of three visits to ostomy nurses and occur much more frequently in people who have had ileostomies than in those who have had colostomies. It has been observed that the prevalence of peristomal skin problems is 21-60% among people who have ileostomies, 13-35% among those who have colostomies and 21-48% among those who have urostomies.

Leakage from ostomies that comes into contact with the skin is thought to predispose the patient to peristomal skin problems. One investigation of peristomal skin problems found that 77% of cases were related to contact with faeces or urine.

There are several reasons why leakage from an ostomy occurs, such as uneven peristomal area, improper handling of the ostomy product or a problematic ostomy (its formation, its location, retraction, prolapse or hernia). The ostomy may also change size with time, which can lead to leakage, if the ostomy products are not adapted accordingly. As a general rule, a check-up of the ostomy by an ostomy nurse or a doctor together with educational support can reduce these problems. Modern ostomy products should, however, also be constantly developed in order to lessen to the greatest extent possible the risk of leakage and associated inconveniences.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

See brief summary

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

List of Inclusion Criteria:

  • Have given written informed consent.
  • Are at least 18 years old.
  • Have mental capacity to understand the study guidelines and questionnaires.
  • Have had their ileostomy for at least 3 months
  • Have an ileostomy with a diameter be-tween 19-40 mm.
  • Are currently using a flat 1-piece product.
  • Are able to change the product by them-selves or with help from a caregiver (e.g. spouse)
  • Have experienced leakage under the base plate at least once a week over the last 2 weeks.

List of Exclusion criteria.

  • Pregnant or breast-feeding.
  • Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
  • Currently using topical steroid product on peristomal skin (injections and oral treatment are accepted).
  • Are currently using a convex product
  • Participating in other clinical studies or have previously participated in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: River
River is a new developed product with Coloplast as manufacturer
Active Comparator: Standard Care
Standard Care can have several manufacture and brand names. Standard Care is defined af the participants currently used stoma care product.

Participants are using their own product and this procedure is called "Standard Care".

Standard Care are the participants own products and may consist of several manufacturer and brand names.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Leakage underneath the baseplate
Time Frame: two weeks
two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peristomal skin condition
Time Frame: Two weeks
Measured by the Ostomy Skin Tool
Two weeks
Security
Time Frame: Two weeks
The participants feeling of security when wearing the product, measured on a 5-point scale
Two weeks
Handling
Time Frame: Two weeks
The participants ease of handling the products, measured on a 5-point scale
Two weeks
Comfort
Time Frame: Two weeks
The participants feeling of comfort when wearing the product, measured on a 5-point scale
Two weeks
Adverse events
Time Frame: Two weeks
Two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Carol Katte, MD, Ashford and St. Peters Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

August 18, 2011

First Submitted That Met QC Criteria

October 6, 2011

First Posted (Estimate)

October 7, 2011

Study Record Updates

Last Update Posted (Estimate)

February 7, 2012

Last Update Submitted That Met QC Criteria

February 6, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CP214OC

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Condition

Clinical Trials on River

3
Subscribe